Biotricity (BTCY) is Developing New Products, Growing Revenues by Triple Digits and Ringing the Opening Bell on the NASDAQ Stock Market

Biotricity (BTCY) is Developing New Products, Growing Revenues by Triple Digits and Ringing the Opening Bell on the NASDAQ Stock Market

Biotricity (BTCY) has consolidated and is bouncing off from support with a gap to fill and an RSI (14) of 36.25

Good day everyone,

Updated coverage on Biotricity, Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company.

Current price $2.76/share (at market close 10-6-21)

Since I covered BTCY three weeks ago the company shares have consolidated creating a “buy the dip” opportunity. We are seeing a lot of these opportunities given the consolidation in the NASDAQ index over that same period.

I also mentioned that “on August 26, 2021, BTCY up listed from the OTCQB Market to the NASDAQ. This brand-new up list to the NASDAQ could broaden awareness among investors as well as opening the door to institutional investors precluded from investing in OTC equities.”

Investor awareness of BTCY is likely exploding as you are reading this because this morning BTCY, this juggernaut with the triple digit revenue growth is RINGING THE OPENING BELL on the NASDAQ stock market. Congratulations to CEO Waqaas Al Siddiq and members of the Biotricity management team on this occasion recognizing all their achievements.

BTCY Highlights

Modest share structure with 46M/shares (est.) outstanding and 31.8M/shares (est.) in the public float.

Triple digit revenue growth,
FYE 3-31-20 $1.4M (+260% YoY)
FYE 3-31-21 $3.3M (+240% YoY)
FYE 3-31-22 (pro forma) $7.0M (+ 215% YoY)

Three analysts have issued recent price targets for BTCY with a consensus price target of $6.67 per share, represent a potential upside of 240% from the current price.

9/10/2021 Maxim Group Reiterated Buy $6.00
7/1/2021 Northland Securities Initiated Outperform $7.00
7/1/2021 Noble Financial Initiated Outperform $7.00

BTCY shares are trading 45% off their 52-week high.

I believe that BTCY has recognized, and is exploiting, a new paradigm in the healthcare system by creating products to allow physicians to monitor patients from remote locations, eliminating the need for office visits just to gather data. BTCY products allow the physician to monitor patient data in real time.

The company has started with products for patients with heart conditions with Bioflux, currently the company’s flagship product. Bioflux®, is a single, integrated mobile cardiac telemetry solution that consists of a proprietary mobile ECG monitoring device and an ECG viewer software package. Bioflux has now been complimented with the new Biokit product. Biokit is a wirelessly connected personal medical device kit that was developed to address the challenges with existing home-based medical devices.

BTCY is creating a seamless, wireless data recording system for cardiac patients that may reduce the number of office visits. Many office visits have the function of just collecting this data that BTCY is making available to your doctor wirelessly and perhaps requiring an office visit only when there is an anomaly in your data. Every patient currently using Bioflux is a candidate for Biokit.

I said above that BTCY is starting with monitoring devices for cardiac patients. Today the company’s focus is the cardiac sector, but we believe their technology could lead them into the diabetic, sleep apnea, and other indications that could benefit from real-time remote data collection as well.

The current setup looks very good.

The Traders News Group


Privacy Policy and Disclaimer
Your Consent
By using our site, you consent to our online privacy policy and disclaimer.
Do we disclose any information to outside parties?
We do not sell your information to anyone. Please see our cookie policy below.
What information do we collect?
We collect information from you when you subscribe to our newsletter or fill out a form on one of our social platforms. This includes your email address and or mobile phone number.
When registering on our site, as appropriate, you may be asked to enter your: e-mail address and or mobile number.
What do we use your information for?
When we collect your email or mobile number it is used for one purpose to send you the information you requested about small cap stocks. Please read our disclaimer carefully before viewing our emails.
Your information, whether public or private, will not be sold, exchanged, transferred, or given to any other company for any reason whatsoever, other than for the express purpose of delivering the information on small cap stocks that you requested.
We send periodic emails
The email address you provide may be used to send you information, the small acp stock reports you requested, respond to inquiries, and/or other requests or questions.
How do we protect your information?
We implement a variety of security measures to maintain the safety of your personal information when you enter, submit, your email address. We use secure third parties to send email and sms messages to you.
Because we value your privacy we have taken the necessary precautions to be in compliance with the California Online Privacy Protection Act.
Online Privacy Policy Policy
This online privacy policy applies to information collected through our website and social media platforms.
Contacting Us
If there are any questions regarding this privacy policy or disclaimer you may contact us using the information below.
Traders News Source is a wholly owned subsidiary of Traders News Source LLC, herein referred to as TNS LLC.
Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our services, joining our site or our email/blog list as well as any social networking platforms we may use.

Please Note: TNS LLC and its employees are not a registered investment advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever.

Release of Liability: Through use of this website viewing or using you agree to hold TNS LLC, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. TNS LLC encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and TNS LLC makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead TNS LLC strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. TNS LLC is compliant with the Can Spam Act of 2003. TNS LLC does not offer such advice or analysis, and TNS LLC further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.
The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, TNS LLC has relied upon information supplied by its customers, publicly available information and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The owners and operators of this website have been compensated twelve thousand five hundred dollars cash via bank wire for our distributed opinions on bcty this week. The advertisements in this website are believed to be reliable, however, TNS LLC and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. TNS LLC is not responsible for any claims made by the companies advertised herein, nor is TNS LLC responsible for any other promotional firm, its program or its structure.
TNS LLC is not affiliated with any exchange, electronic quotation system, the Securities Exchange Commission or FINRA. TNS LLC is not a Broker/Dealer and does not engage in high frequency trading.